One Stop Shop for All Your Market Research Reports

Global Crude Heparin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin. According to our (Global Info Research) latest study, the global Crude Heparin market size was valued at USD 3855.8 million in 2021 and is forecast to a readjusted size of USD 6135.8 million by 2028 with a CAGR of 6.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This report is a detailed and comprehensive analysis for global Crude Heparin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided. Key Features: Global Crude Heparin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2017-2028 Global Crude Heparin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2017-2028 Global Crude Heparin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2017-2028 Global Crude Heparin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2017-2022 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Crude Heparin To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Crude Heparin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Crude Heparin market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Pig Intestine Mucosa Heparin Bovine Heparin and Others Market segment by Application UFH LMWH Major players covered Bioiberica Shenzhen Hepalink Sanofi Nanjing King-friend Fengrun Biological Technology Aspen Oss Hebei Changshan Biochemical Changzhou Qianhong Hepac (Darling Ingredients) Huaian MDC Pharmaceutical Yantai Dongcheng Biochemicals Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Crude Heparin product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Crude Heparin, with price, sales, revenue and global market share of Crude Heparin from 2017 to 2022. Chapter 3, the Crude Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Crude Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Crude Heparin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Crude Heparin. Chapter 14 and 15, to describe Crude Heparin sales channel, distributors, customers, research findings and conclusion.
List of Tables Table 1. Global Crude Heparin Consumption Value by Type, (USD Million), 2017 & 2021 & 2028 Table 2. Global Crude Heparin Consumption Value by Application, (USD Million), 2017 & 2021 & 2028 Table 3. Bioiberica Basic Information, Manufacturing Base and Competitors Table 4. Bioiberica Major Business Table 5. Bioiberica Crude Heparin Product and Services Table 6.
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 730624
Category
  • Pharmaceuticals and Healthcare
Published on 05-Dec
Number of Pages 107
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(53)